Literature DB >> 2553257

Clinical management of familial adenomatous polyposis.

D G Jagelman1.   

Abstract

Familial adenomatous polyposis is a generalized growth disorder. It manifests itself in a catastrophic way with the inevitable development of colorectal cancer if left untreated. The aim of clinical management should be to detect this disease at its earliest possible stage by treatment of the family as a unit and identification of those at risk with appropriate screening. Early surgical intervention with, most commonly, colectomy with ileorectal anastomosis or, in more advanced cases, with colectomy, rectal mucosectomy and ileoanal pouch procedure is appropriate. Following colorectal cancer the major risks of death from this disease include upper gastrointestinal cancer, desmoid tumour and a number of other malignancies throughout the body. The exact magnitude of the risk of malignant degeneration of these extracolonic manifestations is as yet uncertain. Surveillance is required particularly for upper gastrointestinal adenomas, as there is a significant risk for the development of duodenal carcinoma and it is obvious that prophylactic colectomy alone does not cure this disease predictably. The role of a familial polyposis registry in managing these patients is important not only in maintaining compliance with surveillance and therefore early detection of the disease but also in educating the family members and gaining long-term follow-up data on these cases to more accurately define the risk of death from extracolonic malignancy.

Entities:  

Mesh:

Year:  1989        PMID: 2553257

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  4 in total

1.  Non-penetrance and late appearance of polyps in families with familial adenomatous polyposis.

Authors:  D G Evans; S P Guy; N Thakker; J G Armstrong; C Dodd; D R Davies; C Babbs; T Clancy; T Warnes; P Sloan
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

2.  Radical prostatectomy for high grade prostatic intraepithelial neoplasia.

Authors:  R Woderich; J McLoughlin; S Deen
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

Authors:  G Winde; H G Gumbinger; H Osswald; F Kemper; H Bünte
Journal:  Int J Colorectal Dis       Date:  1993-03       Impact factor: 2.571

4.  Health behaviors in patients and families with hereditary colorectal cancer.

Authors:  Allison M Burton; Shelly R Hovick; Susan K Peterson
Journal:  Clin Colon Rectal Surg       Date:  2012-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.